Does C9762 require prior authorization?

Yes, C9762 requires prior authorization (high confidence). Code explicitly requires prior authorization.

`C9762`, Cardiac magnetic resonance imaging for morphology and function, quantification

HCPCS/CPT

Prior Auth Required

Code explicitly requires prior authorization (high confidence)

For Low-dose CT Chest (CPT® 71271) lung cancer screening: documentation that 'all of the criteria are met' for approval per CH-33/CH-33.1/CH-33.2 / NCD 210.14 (i.e., evidence the patient meets the lung cancer screening criteria referenced).
For CT Chest without contrast performed for follow-up of pulmonary nodules: documentation/clinical indication supporting prior detection of pulmonary nodule(s) (i.e., justification for follow-up imaging).
Interrogation report showing device is nearing Elective Replacement Indicator (ERI) or End of Life (EOL).
Interrogation report documenting the device is not functioning correctly and requires replacement.
Clinical documentation that results from speckle‑tracking analysis will inform or change patient management (notes describing intended management decisions based on test results).
When relevant, documentation of FDA clearance/510(k) identifier for the specific speckle‑tracking software used (e.g., K######).

CT Chest without contrast (CPT® 71250) can be used for the following: Patient has contraindication to contrast
CT Chest without contrast (CPT® 71250) can be used for the following: Follow-up of pulmonary nodule(s)
CT Chest without contrast (CPT® 71250) can be used for the following: High Resolution CT (HRCT)
Low-dose CT Chest (CPT® 71271) (See CH-33: Lung Cancer Screening)
Low-dose CT (LDCT) chest for lung cancer screening per CH-33.2: National Coverage Determination (NCD) for Lung Cancer Screening with Low Dose Computed Tomography (LDCT) (210.14) (Medicare)
Low-dose CT Chest (CPT® 71271) may be approved for lung cancer screening annually if all of the criteria are met.

EVICORE-CARDIOVASCULAR_RADIOLOGY-1D1A3C37, Addendum to the eviCore Imaging Guidelines

ANTHEM-RAD.00068, RAD.00068 Myocardial Strain Imaging

RAD601.069, Myocardial Strain Imaging

BCBSIL-RAD601.069, Myocardial Strain Imaging

BCBSMT-RAD601.069, Myocardial Strain Imaging

BCBSNM-RAD601.069, Myocardial Strain Imaging

BCBSOK-RAD601.069, Myocardial Strain Imaging

REGENCE-MED168, Myocardial Strain Imaging

CARELON-imaging-of-the-heart-2025-11-15-updated-2026-05-01, Imaging of the Heart

EVICORE-HPLAN-AETNA-5BB4F6E94100, Aetna Cardiology and Radiology Code List - Effective 01/01/2026

EVICORE-HPLAN-CIGNA-ABA6B3A09755, Cigna Commercial Cardiology Code List - Effective 03/07/2026

EVICORE-HPLAN-CIGNA-1815296EE67F, Cigna Comprehensive Code List - Effective 03/07/2026

EVICORE-HPLAN-CIGNA_MEDICARE-68F4526A04BF, 1199SEIU Radiology and Cardiology Claims Studio Code List - Effective 01/01/2026

EVICORE-HPLAN-CIGNA_MEDICARE-4510B5F98EEE, 1199SEIU Radiology and Cardiology PA Code List - Effective 01/01/2026

EVICORE-HPLAN-EOCCO-F43FD04E5F71, EOCCO Cardiology & Radiology Code List - Effective 01/01/2026

EVICORE-HPLAN-HEALTH_PARTNERS_PLANS-A85DF30B790E, Health Partners Plans Cardiology, Radiology, and Ultrasound Code List – Effective 01/01/2026

EVICORE-HPLAN-HEALTH_PARTNERS_PLANS-CFF312B0BB7B, Health Partners Plans Cardiology, Radiology, and Ultrasound Code List – Effective 07/01/2025

Ask Verity about documentation requirements, denial risks, or coverage in your state.

C9762, Cardiac magnetic resonance imaging for morphology and function, quantification

HCPCS/CPT

Prior Auth Required

Code explicitly requires prior authorization (high confidence)

For Low-dose CT Chest (CPT® 71271) lung cancer screening: documentation that 'all of the criteria are met' for approval per CH-33/CH-33.1/CH-33.2 / NCD 210.14 (i.e., evidence the patient meets the lung cancer screening criteria referenced).
For CT Chest without contrast performed for follow-up of pulmonary nodules: documentation/clinical indication supporting prior detection of pulmonary nodule(s) (i.e., justification for follow-up imaging).
Interrogation report showing device is nearing Elective Replacement Indicator (ERI) or End of Life (EOL).
Interrogation report documenting the device is not functioning correctly and requires replacement.
Clinical documentation that results from speckle‑tracking analysis will inform or change patient management (notes describing intended management decisions based on test results).
When relevant, documentation of FDA clearance/510(k) identifier for the specific speckle‑tracking software used (e.g., K######).

CT Chest without contrast (CPT® 71250) can be used for the following: Patient has contraindication to contrast
CT Chest without contrast (CPT® 71250) can be used for the following: Follow-up of pulmonary nodule(s)
CT Chest without contrast (CPT® 71250) can be used for the following: High Resolution CT (HRCT)
Low-dose CT Chest (CPT® 71271) (See CH-33: Lung Cancer Screening)
Low-dose CT (LDCT) chest for lung cancer screening per CH-33.2: National Coverage Determination (NCD) for Lung Cancer Screening with Low Dose Computed Tomography (LDCT) (210.14) (Medicare)
Low-dose CT Chest (CPT® 71271) may be approved for lung cancer screening annually if all of the criteria are met.